Bandhan Healthcare Fund NFO Opens on November 10, 2025

Bandhan Mutual Fund has announced the launch of its Bandhan Healthcare Fund, an open-ended equity scheme focused on the healthcare and pharmaceutical industries. The new fund offer (NFO) will open for subscription on November 10, 2025, and close on November 24, 2025, providing investors an opportunity to participate in India’s expanding healthcare ecosystem.

Key Details of Bandhan Healthcare Fund

The Bandhan Healthcare Fund is designed to deliver long-term capital appreciation by investing predominantly in equities and equity-related instruments of companies engaged in healthcare, pharmaceuticals, biotechnology, and allied sectors.

The fund requires a minimum investment of ₹1,000 for lump-sum applications and allows systematic investment plans (SIPs) starting from ₹100 per instalment, with a minimum of six instalments.

The scheme will reopen for continuous sale and repurchase within five business days from the date of allotment.

Investment Objective and Strategy

The investment objective of the scheme is to generate long-term capital appreciation by primarily investing in equities and equity-linked securities of companies operating in the healthcare and pharmaceutical sectors. The scheme does not guarantee returns but seeks growth through a research-driven, sectoral approach.

The fund will follow a bottom-up stock selection process, identifying opportunities based on company fundamentals, business scalability, financial performance, and governance standards. It will maintain flexibility across market capitalisation segments, including large, mid, and small-cap stocks.

The fund will invest across segments such as pharmaceuticals, biotechnology, hospitals, healthcare services, medical devices, diagnostics, retail pharmacy, analytics, and wellness. Use of derivatives will be permitted for hedging and portfolio balancing, in line with SEBI regulations.

Associated Risks

Given its sector-specific nature, the fund carries concentration risk tied to performance in healthcare and pharmaceuticals. Other potential risks include regulatory and pricing changes affecting drug manufacturers, market volatility, and currency fluctuations for any overseas investments.

Derivative exposure may result in disproportionate gains or losses, while liquidity risks in equity markets could affect short-term fund performance.

Where Will the Fund Invest?

The Bandhan Healthcare Fund will allocate assets primarily to:

• Equities and equity-related instruments of healthcare and allied companies.

• Healthcare service providers, hospitals, pharmaceutical manufacturers, and retail pharmacy chains.

• Research and analytics firms, biotechnology, and medical equipment makers.

• Select overseas securities within SEBI’s permissible limits.

• Liquid debt and money market instruments for liquidity management.

Read More: Last Day to Invest: JioBlackRock Flexi Cap Fund NFO

Conclusion

The Bandhan Healthcare Fund aims to tap into India’s expanding healthcare landscape, which continues to see strong growth driven by innovation, demographic shifts, and global outsourcing opportunities. With its diversified investment approach, the fund offers investors structured exposure to one of the country’s most promising long-term sectors.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.